Indications and Purposes
| 1 Indications And Usage Cimzia Is A Tumor Necrosis Factor (Tnf) Blocker Indicated For: Reducing Signs And Symptoms Of Crohn's Disease And Maintaining Clinical Response In Adult Patients With Moderately To Severely Active Disease Who Have Had An Inadequate Response To Conventional Therapy ( 1.1 ) Treatment Of Adults With Moderately To Severely Active Rheumatoid Arthritis ( 1.2 ) Treatment Of Adult Patients With Active Psoriatic Arthritis. ( 1.3 ) Treatment Of Adults With Active Ankylosing Spondylitis ( 1.4 ) Treatment Of Adults With Active Non-Radiographic Axial Spondyloarthritis With Objective Signs Of Inflammation ( 1.5 ) Treatment Of Adults With Moderate-To-Severe Plaque Psoriasis Who Are Candidates For Systemic Therapy Or Phototherapy ( 1.6 ) 1.1 Crohn's Disease Cimzia Is Indicated For Reducing Signs And Symptoms Of Crohn's Disease And Maintaining Clinical Response In Adult Patients With Moderately To Severely Active Disease Who Have Had An Inadequate Response To Conventional Therapy. 1.2 Rheumatoid Arthritis Cimzia Is Indicated For The Treatment Of Adults With Moderately To Severely Active Rheumatoid Arthritis (Ra). 1.3 Psoriatic Arthritis Cimzia Is Indicated For The Treatment Of Adult Patients With Active Psoriatic Arthritis (Psa). 1.4 Ankylosing Spondylitis Cimzia Is Indicated For The Treatment Of Adults With Active Ankylosing Spondylitis (As). [See Clinical Studies (14.4) ] 1.5 Non-Radiographic Axial Spondyloarthritis Cimzia Is Indicated For The Treatment Of Adults With Active Non-Radiographic Axial Spondyloarthritis (Nr-Axspa) With Objective Signs Of Inflammation [See Clinical Studies (14.5) ]. 1.6 Plaque Psoriasis Cimzia Is Indicated For The Treatment Of Adults With Moderate-To-Severe Plaque Psoriasis (Pso) Who Are Candidates For Systemic Therapy Or Phototherapy [See Clinical Studies (14.6) ] |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Certolizumab Pegol |